"Study of serious adverse drug reactions using FDA-approved drug labeling ..."

Leihong Wu et al. (2019)

> Home

Details and statistics

DOI: 10.1186/S12859-019-2628-5

access: open

type: Journal Article

metadata version: 2020-03-15

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/bmcbi/WuILZHTZYXMGTF19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/WuILZHTZYXMGTF19
Leihong Wu, Taylor Ingle, Zhichao Liu, Anna Zhao-Wong, Stephen C. Harris, Shraddha Thakkar, Guangxu Zhou, Junshuang Yang, Joshua Xu, Darshan Mehta, Weigong Ge, Weida Tong, Hong Fang:
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA. BMC Bioinform. 20-S(2): 129-139 (2019)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.